Latest EVENTIDE ASSET MANAGEMENT, LLC Stock Portfolio

$5.84Billion– No. of Holdings #159

EVENTIDE ASSET MANAGEMENT, LLC Performance:

2024 Q2: -4.39%YTD: -2.17%2023: 16%

Performance for 2024 Q2 is -4.39%, and YTD is -2.17%, and 2023 is 16%.

About EVENTIDE ASSET MANAGEMENT, LLC and 13F Hedge Fund Stock Holdings

EVENTIDE ASSET MANAGEMENT, LLC is a hedge fund based in BOSTON, MA. On 04-Aug-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $6.1 Billions. In it's latest 13F Holdings report, EVENTIDE ASSET MANAGEMENT, LLC reported an equity portfolio of $5.8 Billions as of 30 Jun, 2024.

The top stock holdings of EVENTIDE ASSET MANAGEMENT, LLC are TT, TMDX, WCN. The fund has invested 4.5% of it's portfolio in TRANE TECHNOLOGIES PLC and 3% of portfolio in TRANSMEDICS GROUP INC.

The fund managers got completely rid off SHOCKWAVE MED INC (SWAV), COURSERA INC (COUR) and SPROUT SOCIAL INC (SPT) stocks. They significantly reduced their stock positions in MONGODB INC (MDB), PRIVIA HEALTH GROUP INC (PRVA) and VERONA PHARMA PLC (VRNA). EVENTIDE ASSET MANAGEMENT, LLC opened new stock positions in NEXTRACKER INC, QUANTA SVCS INC (PWR) and GERON CORP (GERN). The fund showed a lot of confidence in some stocks as they added substantially to NUTANIX INC (NTNX), KYMERA THERAPEUTICS INC (KYMR) and EOG RES INC (EOG).

EVENTIDE ASSET MANAGEMENT, LLC Equity Portfolio Value

Last Reported on: 13 Aug, 2024

EVENTIDE ASSET MANAGEMENT, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that EVENTIDE ASSET MANAGEMENT, LLC made a return of -4.39% in the last quarter. In trailing 12 months, it's portfolio return was -0.16%.

New Buys

Ticker	$ Bought
nextracker inc	36,627,400
quanta svcs inc	31,991,700
geron corp	26,950,200
avalonbay cmntys inc	24,656,700
united therapeutics corp del	21,605,700
dyne therapeutics inc	17,115,600
avidity biosciences inc	15,356,500
international paper co	14,645,000

New stocks bought by EVENTIDE ASSET MANAGEMENT, LLC

Additions

Ticker	% Inc.
nutanix inc	2,900
kymera therapeutics inc	2,236
eog res inc	295
otis worldwide corp	199
axsome therapeutics inc	170
scholar rock hldg corp	103
revolution medicines inc	80.28
rli corp	79.62

Additions to existing portfolio by EVENTIDE ASSET MANAGEMENT, LLC

Reductions

Ticker	% Reduced
mongodb inc	-93.39
privia health group inc	-92.38
verona pharma plc	-75.87
msci inc	-57.99
global e online ltd	-56.27
inari med inc	-44.92
doubleverify hldgs inc	-44.17
bruker corp	-37.34

EVENTIDE ASSET MANAGEMENT, LLC reduced stake in above stock

Sold off

Ticker	$ Sold
coursera inc	-63,311,600
dlocal ltd	-49,436,000
marinus pharmaceuticals inc	-21,212,600
908 devices inc	-10,804,000
sprout social inc	-57,110,500
shockwave med inc	-165,231,000
aerovate therapeutics inc	-13,173,400
alpine immune sciences inc	-16,194,600

EVENTIDE ASSET MANAGEMENT, LLC got rid off the above stocks

Sector Distribution

EVENTIDE ASSET MANAGEMENT, LLC has about 34.8% of it's holdings in Healthcare sector.

Sector	%
Healthcare	34.8
Technology	24.4
Industrials	17.2
Consumer Cyclical	7.8
Others	7
Financial Services	2.1
Energy	2.1
Utilities	1.9
Real Estate	1.3
Basic Materials	1.1

Market Cap. Distribution

EVENTIDE ASSET MANAGEMENT, LLC has about 55.5% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
LARGE-CAP	55.5
MID-CAP	26.4
SMALL-CAP	10.1
UNALLOCATED	7

Stocks belong to which Index?

About 66.5% of the stocks held by EVENTIDE ASSET MANAGEMENT, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index	%
S&P 500	36.9
Others	33.5
RUSSELL 2000	29.6

Top 5 Winners (%)		%
INSM	insmed inc	147.3 %
TMDX	transmedics group inc	103.2 %
ALNY	alnylam pharmaceuticals inc	62.6 %
RNA	avidity biosciences inc	54.1 %
GH	guardant health inc	37.5 %

Top 5 Winners ($)		$
TMDX	transmedics group inc	89.3 M
MIRM	mirum pharmaceuticals inc	32.8 M
GH	guardant health inc	32.4 M
INSM	insmed inc	26.9 M
TT	trane technologies plc	23.1 M

Top 5 Losers (%)		%
ZNTL	zentalis pharmaceuticals inc	-61.8 %
NVDA	nvidia corporation	-50.1 %
SRRK	scholar rock hldg corp	-45.6 %
DV	doubleverify hldgs inc	-44.6 %
RELY	remitly global inc	-37.9 %

Top 5 Losers ($)		$
ZNTL	zentalis pharmaceuticals inc	-112.7 M
EVH	evolent health inc	-41.5 M
DV	doubleverify hldgs inc	-36.8 M
FLYW	flywire corporation	-33.6 M
ODFL	old dominion freight line in	-32.0 M

EVENTIDE ASSET MANAGEMENT, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of EVENTIDE ASSET MANAGEMENT, LLC

EVENTIDE ASSET MANAGEMENT, LLC has 159 stocks in it's portfolio. About 25.3% of the portfolio is in top 10 stocks. ZNTL proved to be the most loss making stock for the portfolio. TMDX was the most profitable stock for EVENTIDE ASSET MANAGEMENT, LLC last quarter.

Last Reported on: 13 Aug, 2024

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
AIP	arteris inc	0.04	348,991	2,620,920	reduced	-12.54

AIT	applied indl technologies in	0.27	80,493	15,615,600	added	53.92

AJG	gallagher arthur j & co	0.88	198,695	51,523,600	added	27.24

ALNY	alnylam pharmaceuticals inc	0.36	87,000	21,141,000	unchanged	0.00

ALPN	alpine immune sciences inc	0.00	0.00	0.00	sold off	-100

ALV	autoliv inc	0.51	278,476	29,794,100	reduced	-1.67

AMGN	amgen inc	0.04	7,169	2,239,950	added	46.22

ANAB	anaptysbio inc	0.24	568,324	14,242,200	added	33.1

APLS	apellis pharmaceuticals inc	0.14	209,794	8,047,700	unchanged	0.00

APTV	aptiv plc	0.30	250,781	17,660,000	added	0.04

ARDX	ardelyx inc	0.85	6,666,980	49,402,300	reduced	-2.14

ARWR	arrowhead pharmaceuticals in	0.21	463,894	12,056,600	added	48.07

AURA	aura biosciences inc	0.75	5,802,680	43,868,300	unchanged	0.00

AVB	avalonbay cmntys inc	0.42	119,178	24,656,700	new

AVTE	aerovate therapeutics inc	0.00	0.00	0.00	sold off	-100

AXSM	axsome therapeutics inc	1.29	938,714	75,566,500	added	170

BBIO	bridgebio pharma inc	0.31	716,927	18,159,800	unchanged	0.00

BPMC	blueprint medicines corp	0.43	231,685	24,971,000	unchanged	0.00

BRKR	bruker corp	0.14	131,812	8,410,920	reduced	-37.34

CBT	cabot corp	0.16	102,547	9,423,040	added	0.38